Recombinant human interleukin 11 and bacterial infection in patients with haemological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial

This publication has 20 references indexed in Scilit:

• 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
  Clinical Infectious Diseases, 2002
• Interleukin-11 induces Th2 polarization of human CD4+ T cells
  Blood, 2001
• Human C-Reactive Protein Is Protective against FatalSalmonella entericaSerovar Typhimurium Infection in Transgenic Mice
  Infection and Immunity, 2000
• Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters
  Oral Oncology, 2000
• IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury
  The Journal of Immunology, 2000
• Additive Effects of Human Recombinant Interleukin-11 and Granulocyte Colony-Stimulating Factor in Experimental Gram-Negative Sepsis
  Blood, 1999
• Phosphorylcholine on the Lipopolysaccharide of Haemophilus influenzae Contributes to Persistence in the Respiratory Tract and Sensitivity to Serum Killing Mediated by C-reactive Protein
  The Journal of Experimental Medicine, 1998
• A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy
  Blood, 1994
• C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
  The Journal of Experimental Medicine, 1981
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958